Comparador de Empresas

Acerca de

Regeneron is a leading biotechnology company built on its proprietary VelociSuite antibody-discovery platform. Dupixent has become one of the best-selling drugs globally, and the company's deep pipeline of bispecific antibodies and next-gen immunotherapies positions it for continued growth beyond its current blockbusters.

Ingresos

$16.2B

Señal de brecha de noticias

Señales institucionales

Patrones en cascada

Relaciones clave

Acerca de

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

Ingresos

$130.5B

Señal de brecha de noticias

Señales institucionales

Patrones en cascada

Relaciones clave